Davis Michael J, Scallan Joshua P, Castorena-Gonzalez Jorge A, Kim Hae Jin, Ying Lim Hwee, Pin Yeo Kim, Angeli Veronique
Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, United States.
Department of Molecular Pharmacology, University of South Florida, Tampa, FL, United States.
Front Physiol. 2023 Jan 6;13:1098408. doi: 10.3389/fphys.2022.1098408. eCollection 2022.
Rodent models of cardiovascular disease have uncovered various types of lymphatic vessel dysfunction that occur in association with atherosclerosis, type II diabetes and obesity. Previously, we presented evidence for impaired lymphatic drainage in apolipoprotein E null ( ) mice fed a high fat diet (HFD). Whether this impairment relates to the dysfunction of collecting lymphatics remains an open question. The mouse is a well-established model of cardiovascular disease, in which a diet rich in fat and cholesterol on an deficient background accelerates the development of hypercholesteremia, atherosclerotic plaques and inflammation of the skin and other tissues. Here, we investigated various aspects of lymphatic function using tests of collecting lymphatic vessels from or mice fed a HFD. Popliteal collectors were excised from either strain and studied under defined conditions in which we could quantify changes in lymphatic contractile strength, lymph pump output, secondary valve function, and collecting vessel permeability. Our results show that all these aspects of lymphatic vessel function are altered in deleterious ways in this model of hypercholesterolemia. These findings extend previous observations suggesting significant dysfunction of lymphatic endothelial cells and smooth muscle cells from collecting vessels in association with a HFD on an -deficient background. An implication of our study is that collecting vessel dysfunction in this context may negatively impact the removal of cholesterol by the lymphatic system from the skin and the arterial wall and thereby exacerbate the progression and/or severity of atherosclerosis and associated inflammation.
心血管疾病的啮齿动物模型已揭示出与动脉粥样硬化、II型糖尿病和肥胖相关的各种类型的淋巴管功能障碍。此前,我们提供了证据表明,喂食高脂饮食(HFD)的载脂蛋白E基因敲除( )小鼠存在淋巴引流受损的情况。这种损伤是否与集合淋巴管的功能障碍有关仍是一个悬而未决的问题。 小鼠是一种成熟的心血管疾病模型,在缺乏 的背景下,富含脂肪和胆固醇的饮食会加速高胆固醇血症、动脉粥样硬化斑块以及皮肤和其他组织炎症的发展。在此,我们使用从喂食HFD的 或 小鼠收集的集合淋巴管进行测试,研究了淋巴管功能的各个方面。从任一品系中切除腘窝集合淋巴管,并在特定条件下进行研究,在此条件下我们可以量化淋巴管收缩强度、淋巴泵输出量、次级瓣膜功能和集合血管通透性的变化。我们的结果表明,在这种高胆固醇血症模型中,淋巴管功能的所有这些方面都以有害的方式发生了改变。这些发现扩展了先前的观察结果,表明在缺乏 的背景下,与HFD相关的集合血管中的淋巴管内皮细胞和平滑肌细胞存在明显的功能障碍。我们研究的一个启示是,在这种情况下,集合血管功能障碍可能会对淋巴系统从皮肤和动脉壁清除胆固醇产生负面影响,从而加剧动脉粥样硬化及相关炎症的进展和/或严重程度。
Front Physiol. 2023-1-6
Front Pharmacol. 2022-3-4
Atherosclerosis. 2019-1-31
J Am Heart Assoc. 2017-9-22
Arterioscler Thromb Vasc Biol. 2017-11-21
J Lipid Res. 2025-4
Function (Oxf). 2024-9-10
Front Cell Dev Biol. 2024-2-21
Clin Sci (Lond). 2023-9-27
Trends Pharmacol Sci. 2022-11
Am J Physiol Cell Physiol. 2022-10-1
Front Pharmacol. 2022-3-4
J Clin Invest. 2021-7-15